Name: Dr Alexandra Stewart
Job title: Consultant Clinical Oncologist, Clinical Lead for Oncology
GMC number: 4424011
Qualifications: BM, DM, MRCP, FRCR
Lower bowel cancer
Clinical nurse specialist:
Practice locations: RSCH, ESH
Private Practice: Nuffield Hospital, Guildford
(NHS) Sue Letheren
Ext: 6929 09.00-17.00 Mon-Fri (or cover)
(Private) Heather Scott
The Guildford Nuffield Hospital
Guildford GU2 7RF
Tel: 01483 207334
Fax: 01483 571394
Hours of work: Mon: 08.00 – 12.00
Tues: work from home *
Weds: 08.00 – 12.00
Thurs 08.00 – 15.30
Fri 12.30 – 15.30
Dr Alex Stewart went to medical school at Southampton University. She developed an initial interest in oncology at the Royal Marsden Hospital working on primary prevention of breast cancer studies in the Professorial unit. She then commenced specialist registrar training at Charing Cross and the Hammersmith Hospitals where amongst other interests she gained initial experience in brachytherapy. She was then chosen for a prestigious Fellowship at the Brigham and Women’s Hospital, Harvard University in Boston where she completed a year of brachytherapy training and a year of prostate cancer Fellowship on a National Institute of Health grant. Whilst there she won an ASCO merit award for a prostate cancer study that was subsequently published in the high profile Journal of Clinical Oncology.
She returned from the USA to complete her specialist registrar training at the Royal Marsden Hospital where she continued to publish on specialist radiotherapy techniques such as IMRT in lower limb sarcomas. On completing her specialist training she chose to work in Guildford due to the exemplary brachytherapy department they had. They were very strong in prostate brachytherapy and Alex has now developed their cervix brachytherapy and added oesophageal and rectal brachytherapy to the portfolio, one of few international centres to perform this.
Alex has kept her research links strong, holding an honorary contract at the University of Surrey as a Visiting Senior Lecturer. She is leading a study on cervix IMRT and another on the use of PET scanning in early cervix cancer. She is also developing improved imaging techniques in cervix brachytherapy and collaborating with the University physics and engineering departments in innovative projects. She has developed the rectal brachytherapy service and is involved in the international OPERA trial investigating Papillon radiotherapy and has also developed a National database to follow patients who undergo Papillon treatment.